0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.16%
Revenue growth under 50% of 3606.HK's 14.98%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
20.10%
Positive gross profit growth while 3606.HK is negative. John Neff would see a clear operational edge over the competitor.
8.18%
Positive EBIT growth while 3606.HK is negative. John Neff might see a substantial edge in operational management.
8.18%
Positive operating income growth while 3606.HK is negative. John Neff might view this as a competitive edge in operations.
85.09%
Positive net income growth while 3606.HK is negative. John Neff might see a big relative performance advantage.
84.38%
Positive EPS growth while 3606.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
85.94%
Positive diluted EPS growth while 3606.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.85%
Share reduction while 3606.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
1.22%
Diluted share change of 1.22% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
6.96%
Maintaining or increasing dividends while 3606.HK cut them. John Neff might see a strong edge in shareholder returns.
-10.98%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.47%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-35.10%
Negative 10Y revenue/share CAGR while 3606.HK stands at 102.22%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-46.64%
Negative 5Y CAGR while 3606.HK stands at 26.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.46%
Negative 3Y CAGR while 3606.HK stands at 25.05%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-8146.73%
Negative 10Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
36.76%
5Y OCF/share CAGR above 1.5x 3606.HK's 18.67%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-85.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-196.54%
Negative 10Y net income/share CAGR while 3606.HK is at 29.35%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-102.54%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-108.70%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
88.86%
Below 50% of 3606.HK's 242.56%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-3.72%
Negative 5Y equity/share growth while 3606.HK is at 43.69%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-12.03%
Negative 3Y equity/share growth while 3606.HK is at 28.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-18.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.37%
AR growth is negative/stable vs. 3606.HK's 9.17%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
20.84%
Inventory growth well above 3606.HK's 10.17%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.58%
Positive asset growth while 3606.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.91%
BV/share growth above 1.5x 3606.HK's 1.87%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-3.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
146.15%
R&D growth drastically higher vs. 3606.HK's 12.03%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.01%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.